; DIAGNOSTIC AND STATISTICAL
`
`MANUAL OF
`
`MENTAL DISORDERS
`
` Page 1 of 114 SLAYBACK EXHIBIT 1024
`
`
`
`Page 1 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`DSM-5® Diagnostic Criteria
`Mobile App
`'
`
`An essential digital companion to DSM-5®
`
`The DSM-S® Diagnostic Criteria Mobile App is designed to help mental
`health practitioners, researchers, and students fully integrate the new
`DSM criteria and codes into their practice and study. Users have full offline
`. Ccess to all of the criteria sets as well as online access to supporting
`yideos, commentary, and resources. Powerful search and customization
`tools aid and enhance assessment of symptom presentations in a variety
`1 of clinical and administrative settings. It features:
`
`~ Access to the complete DSM—S diagnostic criteria sets on your
`phone and tablet
`
`- iCD—9~CM and ICD-lo—CM codes for clinical and administrative use
`
`- Video commentary from DSM-S task force members highlighting
`changes from DSM-lV to DSM—S
`
`' Robust disorder, acronym, code, and symptom search functionality
`
`. Bookmarking that allows customization of the criteria sets most
`commonly referenced
`
`- Spanish language supported
`
`The DSM-5® Diagnostic Criteria Mobile App is updated periodically
`to reflect coding updates, changes, and corrections.
`
`Available through App/e App Store and Goog/e Play
`
` Page 2 of 114 SLAYBACK EXHIBIT 1024
`
`
`
`Page 2 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`
`
`DIAGNOSTIC AND STATISTICAL
`MANUAL OF
`MENTAL DISORDERS
`
`DSM-5®
`
`
`
`Page3of114
`
`SLAYBACK EXHIBIT 1024
`
`Page 3 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`American Psychiatric Association
`
`Ofi‘z‘cers 2012—2013
`
`PRESIDENT DILIP V. JESTE, MD.
`PRESIDENT-ELECT JEFFREY A. LIEBERMAN, MD.
`TREASURER DAVID FASSLER, MD.
`
`SECRETARY ROGER PEELE, MD.
`
`MEMBER—IN-TRAINING TRUSTEE-ELECT
`
`Assembly
`SPEAKER R. SCOTT BENSON, MD.
`SPEAKER—ELECT MELINDA L. YOUNG, MD.
`
`Board of Trustees
`JEFFREY AKAKA, MD.
`
`CAROL A. BERNSTEIN, MD.
`
`BRIAN CROWLEY, MD.
`
`ANITA S. EVERETT, MD.
`
`JEFFREY GELLER, MD., MPH.
`
`MARC DAVID GRAFF, MD.
`
`JAMES A. GREENE, MD.
`JUDITH F. KASHTAN, MD.
`MOLLY K. MCVOY, MD.
`
`JAMES E. NININGER, MD.
`
`JOHN M . OLDHAM, MD.
`
`ALAN F. SCHATZBERG, MD.
`ALIK S. WIDGE, MD, PHD.
`
`ERIK R. VANDERLIP, MD.,
`
`P
`
`age
`
`4 of 114
`
`SLAYBACK EXHIBIT 1024
`
`Page 4 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`ation
`
`DIAGNOSTIC AND STATISTICAL
`MANUAL OF
`MENTAL DISORDERS
`
`DSM-S®
`
`
`
`
`
`I.
`
`
` AME RRRRR
`PSYCHIATRIC
`_ AS_SOCI_AAAAA
`PUBLISHING
`
`Page 5 of 114
`
`SLAYBACK EXHIBIT 1024
`
`Page 5 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`Copyright © 2013 American Psychiatric Association
`
`issions should be directed to DSM Permissions,
`, 800 Maine Ave., S.W., Washington, DC 20024.
`Manufactured in the United States of America on acid-free paper.
`ISBN 978-0-89042-554-1 (Hardcover) 4th printing October 2018
`ISBN 978-0-89042—555-8 (Paperback) 7th printing October 2018
`American Psychiatric Association
`800 Maine Ave., SW
`Washington, DC 20024
`www.psych.org
`
`Library of Congress Cataloging-in-Publication Data
`Diagnostic and statistical manual of me
`
`Includes index.
`
`ISBN 978-0-89042-554-1 (hardcover : alk. paper) ~ ISBN 978—0-89042-555-8 (pbk. :
`I. American Psychiatric Association. II. A
`merican Psychiatric Association. DSM-S
`III. Title: DSM-5. IV. Title: DSM-V.
`
`Manufacturing~Sheridan Books, Inc.
`
`
`
`RC455.2.C4
`616.89'075~dc23
`
`British Libra
`A CIP record
`
`ry Cataloguing in Publication Data
`is available from the British Library.
`Text Design~Tammy J. Cordova
`
`2013011061
`
`Page 6 of 114
`
`SLAYBACK EXHIBIT 1024
`
`Page 6 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`iation. Use of
`iation,
`
`his book may
`,8 prohibition
`applications.
`
`Permissions,
`1, DC 20024.
`
`and Statisti-
`tric Associa-
`
`alk. paper)
`Task ForCe.
`
`Disorders‘
`
`2013011061
`
`Contents
`
`DSM—5 Classification ................................... xiii
`Preface ............................................... xli
`
`Section I
`
`DSM-S Basics
`
`Introduction ............................................5
`Use of the Manual ...................................... 19
`Cautionary Statement for Forensic Use of DSM-5 ............ 25
`
`Section II
`Diagnostic Criteria and Codes
`Neurodevelopmental Disorders ...........................31
`Schizophrenia Spectrum and Other Psychotic Disorders ......87
`Bipolar and Related Disorders ........................... 123
`Depressive Disorders .................................. 155
`Anxiety Disorders...................................... 189
`Obsessive—Compulsive and Related Disorders .............235
`Trauma- and Stressor—Related Disorders ..................265
`Dissociative Disorders ................................. 291
`Somatic Symptom and Related Disorders ................. 309
`Feeding and Eating Disorders ...........................329
`Elimination Disorders ..................................355
`Sleep-Wake Disorders..................................361
`Sexual Dysfunctions ...................................423
`Gender Dysphoria .....................................451
`
`
`
`Page7of114
`
` SLAYBACK EXHIBIT 1024
`
`Page 7 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`Disruptive, Impulse-Control, and Cor'duct Disorders ........ 461
`Substance-Related and Addictive Disorders ............... 481
`Neurocognitive Disorders............................... 591
`Personality Disorders .................................. 645
`Paraphilic Disorders ................................... 685
`Other Mental Disorders ................................ 707
`Medication-Induced Movement Disorders
`and Other Adverse Effects of Medication ................ 709
`Other Conditions That May Be a Focus of Clinical Attention . .715
`
`'u
`a
`'
`‘l
`.
`Assessment Measures ................................. 733
`Cultural Formulation ................................... 749
`Alternative DSM-5 Model for Personality Disorders ......... 761
`Conditions for Further Study ............................ 783
`
`Highlights of Changes From DSM-lV to DSM-5 ............. 809
`Glossary of Technical Terms ............................ 817
`Glossary of Cultural Concepts of Distress ................. 833
`Alphabetical Listing of DSM-5 Diagnoses and Codes
`(lCD-9-CM and lCD-10-CM) ............................ 839
`Numerical Listing of DSM-5 Diagnoses and Codes
`(lCD-9-CM) ......................................... 863
`Numerical Listing of DSM-5 Diagnoses and Codes
`(lCD-10-CM) ........................................ 877
`DSM-5 Advisors and Other Contributors .................. 897
`
`Index ................................................ 917
`
`
`
`Page 8 o
`
`f 114
`
`SLAYBACK EXHIBIT 1024
`
`Page 8 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`.
`
`-
`
`----- 461
`.
`.
`.
`. . 481
`..... 591
`
`' '
`
`'
`-
`
`'
`-
`
`' 645
`- 685
`707
`
`- 709
`- 715
`
`0" -
`
`'
`
`' 7‘33
`749
`'
`_ 761
`- 783
`
`_
`
`.
`
`809
`'
`. 817
`. 833
`
`. 839
`
`. 863
`877
`897
`
`'
`
`. 917
`
`DSM-5 Task Force
`
`DAVID J. KUPFER, MD.
`Task Force Chair
`DARREL A. REGIER, M.D., MPH.
`Task Force Vice—Chair
`William E. Narrow, M.D., M.P.H.,
`Susan K. Schultz, M.D., Text Editor
`Research Director
`Emily A. Kuhl, Ph.D., APA Text Editor
`Dan G. Blazer, M.D., Ph.D., MPH.
`Charles P. O’Brien, M.D., PhD.
`Jack D. Burke Jr., M.D., MPH.
`Roger Peele, MD.
`William T. Carpenter Jr., MD.
`Katharine A. Phillips, MD.
`F. Xavier Castellanos, MD.
`Daniel S. Pine, MD.
`Wilson M. Compton, M.D., M.P.E.
`Charles F. Reynolds III, MD.
`Joel E. Dimsdale, MD.
`Maritza Rubic—Stipec, SCD.
`Javier I. Escobar, M.D., M.Sc.
`David Shaffer, MD.
`Jan A. Fawcett, MD.
`Andrew E. Skodol 11, MD.
`Bridget F. Grant, Ph.D., PhD. (2009—)
`Susan E. Swedo, MD.
`Steven E. Hyman, MD. (2007—2012)
`B. Timothy Walsh, MD.
`Dilip V. Jeste, MD. (2007—201 1)
`Philip Wang, M.D., Dr.P.H. (2007—2012)
`Helena C. Kraemer, PhD.
`William M. Womack, MD.
`Daniel T. Mamah, M.D., M.P.E.
`Kimberly A. Yonkers, MD.
`James P. McNulty, A.B., Sc.B.
`Kenneth J. Zucker, PhD.
`Howard B. Moss, MD. (2007—2009)
`NormanSartorius,M.D.,Ph.D., Consultant
`APA Division of Research Staff on DSM-5
`Darrel A. Regier, M.D., M.P.H.,
`Jennifer J. Shupinka, Assistant Director,
`Director, Division ofResearch
`DSM Operations
`William E. Narrow, M.D., M.P.H.,
`Seung—Hee Hong, DSM Senior Research
`Associate Director
`Associate
`Emily A. Kuhl, Ph.D., Senior Science
`Anne R. Hiller, DSM Research Associate
`Writer; StafirText Editor
`Alison S. Beale, DSM Research Associate
`Diana E. Clarke, Ph.D., M.Sc., Research
`Spencer R. Case, DSM Research Associate
`Statistician
`Lisa H. Greiner, M.S.S.A., DSM—5 Field
`Trials Project Manager
`Eve K. Moscicki, Sc.D., M.P.H.,
`Director, Practice Research Network
`S. Janet Kuramoto, PhD. M.H.S.,
`Senior Scientific Research Associate,
`PracticeResearchNetwork
`Amy Porfiri, M.B.A.
`Director ofFinance and Administration
`
`Joyce C. West, Ph.D., M.P.P.,
`Health Policy Research Director, Practice
`Research Network
`Farifteh F. Duffy, Ph.D.,
`Quality Care Research Director, Practice
`Research Network
`Lisa M. Countis, Field Operations
`Manager, Practice Research Network
`Christopher M. Reynolds,
`Executive Assistant
`
`APA Office of the Medical Director
`
`JAMES H. SCULLY 111., MD.
`Medical Director and CEO
`
`'
`
`
`
`Page90f114
`
` SLAYBACK EXHIBIT 1024
`
`Page 9 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`Editorial and Coding Consultants
`
`Michael B. First, MD.
`
`Maria N. Ward, M.Ed., RHIT, CCS-P
`
`DSM-5 Work Groups
`
`ADHD and Disruptive Behavior Disorders
`DAVID SHAFFER, MD.
`‘
`Chair
`
`F. XAVIER CASTELLANOS, MD.
`Co—Chair
`
`Paul J. Frick, Ph.D., Text Coordinator
`Luis Augusto Rohde, M.D., ScD.
`Glorisa Canino, PhD.
`Rosemary Tannock, PhD.
`Terrie E. Moffitt, PhD.
`Eric A. Taylor, M.B.
`Joel T. Nigg, PhD.
`Richard Todd, Ph.D., MD. (d. 2008)
`Anxiety, Obsessive-Compulsive Spectrum, Posttraumatic,
`and Dissociative Disorders
`
`KATHARINE A. PHILLIPS, MD.
`Chair
`
`Michelle G. Craske, Ph.D., Text
`Coordinator
`J. Gavin Andrews, MD.
`Susan M. Bogels, PhD.
`Matthew J. Friedman, M.D., PhD.
`Eric Hollander, MD. (2007—2009)
`Roberto Lewis-Fernandez, M.D., M.T.S.
`Robert S. Pynoos, M.D., M.P.H.
`
`Scott L. Rauch, MD.
`H. Blair Simpson, M.D., PhD.
`David Spiegel, MD.
`Dan J. Stein, M.D., PhD.
`Murray B. Stein, MD.
`Robert J. Ursano, MD.
`Hans—Ulrich Wittchen, PhD.
`
`
`
`Childhood and Adolescent Disorders
`DANIEL S. PINE, MD.
`Chair
`
`Ronald E. Dahl, MD.
`E. Jane Costello, PhD. (2007—2009)
`Regina Smith James, MD.
`Rachel G. Klein, PhD.
`
`James F. Leckman, MD.
`Ellen Leibenluft, MD.
`Judith H. L. Rapoport, MD.
`Charles H. Zeanah, MD.
`
`Eating Disorders
`B. TIMOTHY WALSH, MD.
`Chair
`
`Stephen A. Wonderlich, Ph.D.,
`Text Coordinator
`Evelyn Attia, MD.
`Anne E. Becker, M.D., Ph.D., Sc.M.
`Rachel Bryant-Waugh, MD.
`Hans W. Hoek, M.D., PhD.
`
`Richard E. Kreipe, MD.
`Marsha D. Marcus, PhD.
`James E. Mitchell, MD.
`Ruth H. Striegel-Moore, PhD.
`G. Terence Wilson, PhD.
`Barbara E. Wolfe, PhD. A.P.R.N.
`
`Page100f114
`
`SLAYBACK EXHIBIT 1024
`
`Page 10 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`
`
`
`
`Mood Disorders
`
`JAN A. FAWCETT, MD.
`Chair
`
`Ellen Frank, PhD., Text Coordinator
`Jules Angst, MD. (2007—2008)
`William H. Coryell, MD.
`Lori L. Davis, MD.
`Raymond J. DePaulo, MD.
`Sir DaVid Goldberg, MD.
`James S. Jackson, PhD.
`
`Kenneth S. Kendler, MD.
`(2007—2010)
`Mario Maj, M.D., PhD.
`Husseini K. Manji, MD. (2007—2008)
`Michael R. Phillips, MD.
`Trisha Suppes, M.D., PhD.
`Carlos A. Zarate, MD.
`
`Neurocognitive Disorders
`DILIP V. JESTE, MD. (2007—2011)
`Chair Emeritus
`
`DAN G. BLAZER, M.D., PH.D., M.P.H.
`Chair
`
`RONALD C. PETERSEN, M.D., PHD.
`Co—Chair
`
`Mary Ganguli, M.D., M.P.H.,
`Text Coordinator
`Deborah Blacker, M.D., ScD.
`Warachal Faison, MD. (2007—2008)
`
`Igor Grant, MD.
`Eric J. Lenze, MD.
`Jane S. Paulsen, PhD.
`Perminder S. Sachdev, M.D., PhD.
`
`Neurodevelopmental Disorders
`SUSAN E. SWEDO, MD.
`Chair
`
`Gillian Baird, M.A., M.B., B.Chir.,
`Text Coordinator
`Edwin H. Cook Jr., MD.
`Francesca G. Happé, PhD.
`James C. Harris, MD.
`Walter E. Kaufmann, MD.
`Bryan H. King, MD.
`Catherine E. Lord, PhD.
`
`Joseph Piven, MD.
`Sally J. Rogers, PhD.
`Sarah J. Spence, M.D., PhD.
`Rosemary Tannock, PhD.
`Fred Volkrnar, MD. (2007—2009)
`Amy M. Wetherby, PhD.
`Harry H. Wright, MD.
`
`Personality and Personality Disorders1
`ANDREW E. SKODOL, MD.
`Chair
`
`JOHN M. OLDHAM, MD.
`Co—Chair
`
`Robert F. Krueger, Ph.D., Text
`Coordinator
`Renato D. Alarcon, M.D., M.P.‘H.
`Carl C. Bell, MD.
`Donna S. Bender, PhD.
`
`Lee Anna Clark, PhD.
`W. John Livesley, M.D., PhD. (2007—2012)
`Leslie C. Morey, PhD.
`Larry J. Siever, MD.
`Roe] Verheul, PhD. (2008—2012)
`
`1
`
`The members of the Personality and Personality Disorders Work Group are responsible for the
`alternative DSM-S model for personality disorders that is included in Section III. The Section II
`personality disorders criteria and text (with updating of the text) are retained from DSM—IV—TR.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` Page11of114
`SLAYBACK EXHIBIT 1024
`
`Page 11 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`Psychotic Disorders
`WILLIAM T. CARPENTER JR, M.D.
`Chair
`
`Deanna M. Barch, Ph.D., Text
`Coordinator
`
`Juan R. Bustillo, M.D.
`Wolfgang Gaebel, M.D.
`Raquel E. Gur, M.D., Ph.D.
`Stephan H. Heckers, M.D.
`
`Dolores Malaspina, M.D., M.S.P.H.
`Michael]. Owen, M.D., PhD.
`Susan K. Schultz, M.D.
`Rajiv Tandon, MD.
`Ming T. Tsuang, M.D., PhD.
`Jim van Os, M.D.
`
`Sexual and Gender Identity Disorders
`KENNETH J. ZUCKER, PHD.
`Chair
`
`Lori Brotto, Ph.D., Text Coordinator
`Irving M. Binik, PhD.
`Ray M. Blanchard, PhD.
`Peggy T. Cohen-Kettenis, PhD.
`Jack Drescher, M.D.
`Cynthia A. Graham, PhD.
`
`Martin P. Kafka, MD.
`Richard B. Krueger, MD.
`Niklas LangstrOm, M.D., PhD.
`Heino FL. Meyer—Bahlburg, Dr. rer. nat.
`Friedemann Pf'afflin, MD.
`Robert Taylor Segraves, M.D., PhD.
`
`Sleep-Wake Disorders
`CHARLES F. REYNOLDS III, M.D.
`Chair
`
`Ruth M. O’Hara, Ph.D., Text Coordinator
`Charles M. Morin, PhD.
`Allan 1. Pack, PhD.
`
`Kathy P. Parker, Ph.D., R.N.
`Susan Redline, M.D., MPH.
`Dieter Riemann, PhD.
`
`Somatic Symptom Disorders
`JOEL E. DIMSDALE, M.D.
`Chair
`
`James L. Levenson, M.D., Text
`Coordinator
`
`Arthur]. Barsky lII, MD.
`Francis Creed, MD.
`Nancy Frasure—Smith, PhD. (2007—2011)
`
`Michael R. Irwin, MD.
`Francis]. Keefe, PhD. (2007—2011)
`Sing Lee, MD.
`Michael Sharpe, MD.
`Lawson R. Wulsin, MD.
`
`Substance-Related Disorders
`CHARLES P. O’BRIEN, M.D., PHD.
`Chair
`
`
`
`THOMAS]. CROWLEY, M.D.
`Co—Chair
`-/
`
`Wilson M. Compton, M.D., M.P.E
`Text Coordinator
`Marc Auriacombe, MD.
`Guilhcrme L. G. Borges, M.D., Dr.Sc.
`Kathleen K. Bucholz, PhD.
`Alan I. Budney, PhD.
`Bridget F. Grant, Ph.D., PhD.
`Deborah S. Hasin, PhD.
`
`Thomas R. Kosten, MD. (2007~2008)
`Walter Ling, M.D.
`Spero M. Manson, PhD. (2007—2008)
`A. Thomas McLellan, PhD. (2007—2008)
`Nancy M. Petry, PhD.
`Marc A. Schuckit, M.D.
`Wim van den Brink, M.D., PhD.
`(2007—2008)
`
`Page 12 of114
`
`SLAYBACK EXHIBIT 1024
`
`Page 12 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`DSM-5 Study Groups
`
`Diagnostic Spectra and DSM/ICD Harmonization
`STEVEN E. HYMAN, MD.
`Chair (2007—2012)
`
`William T. Carpenter Jr., MD.
`Wilson M. Compton, M.D., M.P.E.
`Jan A. Fawcett, M.D.
`Helena C. Kraemer, PhD.
`David]. Kupfer, MD.
`
`William E. Narrow, M.D., M.P.H.
`Charles P. O’Brien, M.D., PhD.
`John M. Oldham, M.D.
`Katharine A. Phillips, MD.
`Darrel A. Regier, M.D., M.P.H.
`
`Lifespan Developmental Approaches
`ERIC J. LENZL“, MD.
`Chair
`
`SUSAN K. SCHULTZ, MD.
`Chair Emeritus
`
`DANIEL S. PINE, MD.
`Chair Emeritus
`
`B. Timothy Walsh, MD.
`
`Dan G. Blazer, M.D., PhD., M.P.H.
`F. Xavier Castellanos, MD.
`Wilson M. Compton, M.D., M.P.E.
`
`Daniel T. Mamah, M.D., M.P.E.
`Andrew E. Skodol Tl, MD.
`Susan E. Swedo, MD.
`
`Gender and Cross-Cultural Issues
`
`KIMBERLY A. YONKERS, MD.
`Chair
`
`ROBERTO LEWIS-FERNANDEZ, M.D., M.T.S.
`Co-CImz'r, Cross-Cultural Issues
`
`Renato D. Alarcon, M.D., M.P.H.
`Diana E. Clarke, PhD., M.Sc,
`Javier I. Escobar, M.D., M.Sc.
`Ellen Frank, PhD.
`James S. Jackson, PhD.
`Spiro M. Manson, PhD. (2001-2008)
`James P. McNulty, A.B., SOB.
`
`Leslie C. Morey, PhD.
`William E. Narrow, M.D., M.P.H.
`Roger Poole, MD.
`Philip Wang, M.D., Dr.P.H. (2007-2012)
`William M. Womack, MD.
`Kenneth J. Zucker, PhD.
`
`Psychiatric/General Medical Interface
`LAWSON R. WULSIN, MD.
`Chair
`
`Ronald E. Dahl, MD.
`Joel E. Dimsdale, MD.
`_ Javier l. Escobar, M.D., M.Sc.
`_ Dilip V. Jeste, MD. (2007»2011)
`. Walter E. Kaufmann, MD.
`
`Richard E. Kreipe, MD.
`Ronald C. Petersen, PhD., MD.
`Charles F. Reynolds III, MD.
`Robert Taylor Segraves, M.D., PhD.
`
`Page 13 of 114
`
`SLAYBACK EXHIBIT 1024
`
`Page 13 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`Impairment and Disability
`JANE S. PAULsEN, PHD.
`Chair
`
`I. Gavin Andrews, MD.
`Glorisa Canino, PhD.
`Lee Anna Clark, l’hD.
`Diana E. Clarke, PhD., M.Sc.
`Michelle G. Craske, PhD.
`
`Hans W. Hoek, M.D., PhD.
`Helena C. Kraemer, PhD.
`William E. Narrow, M.D., M.P.H.
`David Shaffer, MD.
`
`Diagnostic Assessment Instruments
`
`JACK D. BURKE JR, M.D., MPH.
`Chair
`
`Lee Anna Clark, PhD.
`Diana E. Clarke, PhD., M.Sc.
`Bridget F. Grant, PhD, PhD.
`
`Helena C. Kraemer, PhD.
`William E. Narrow, M.D., M.P.H.
`David Shaffer, MD.
`
`
`
`DSM—5 Research Group
`
`WILLIAM E. NARROW, M.D., MPH.
`Chair
`
`Jack D. Burke Jr, M.D., M..P.H.
`Diana E. Clarke, Ph.D., M.Sc.
`Helena C. Kraemer, PhD.
`
`David I. Kupfer, MD.
`Darrel A. Regier, M.D., M.P.H.
`David Shaffer, MD.
`
`Course Specifiers and Glossary
`WOLFGANG GAEBEL, MD.
`Chair
`
`Ellen Frank, PhD.
`Charles P. O'Brien, M.D., PhD.
`Norman Sartorius, M.D., PhD.,
`Consultant
`Susan K. Schultz, MD.
`
`Dan J. Stein, M.D., PhD.
`Eric A. Taylor, M.B.
`David I. Kupfer, MD.
`Darrel A. Regier, M.D., M.P.H.
`
`Page 14 of114
`
`SLAYBACK EXHIBIT 1024
`
`Page 14 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`
`
`VI.P.H.
`
`VLPI-I.
`
`
`
`
`
`Before each disorder name, ICD-9—CM codes are provided, followed by ICD-lO-CM codes
`in parentheses. Blank lines indicate that either the ICD—9—CM or the ICD—IO-CM code is not
`applicable. For some disorders, the code can be indicated only according to the subtype or
`specifier.
`ICD—9—CM codes are to be used for coding purposes in the United States through Sep—
`tember 30, 2015. ICD—lO—CM codes are to be used starting October 1, 2015. For DSM-S cod—
`mg and other updates, see the DEM—5® Update on www.PsychiatryOnlinc.org.
`Following chapter titles and disorder names, page numbers for the corresponding text
`r criteria are included in parentheses.
`Note for all mental disorders due to another medical condition: Indicate the name of
`L he other medical condition in the name of the mental disorder due to [the medical condi-
`tion]. The code and name for the other medical condition should be listed first immedi—
`ately before the mental disorder due to the medical condition.
`
`Neumdevelropmenta' .,P_i_.5..9f§ers (31)
`
`nteilectual Disabilities (33)
`
`.M {,,,,,,,,tvvvvvv)
`
`Intellectual Disability (Intellectual Developmental Disorder) (33)
`Specify current severity:
`Mild
`Moderate
`
`Unspecified Communication Disorder (49)
`
`Severe
`Profound
`
`Global Developmental Delay (41)
`
`Unspecified Intellectual Disability (Intellectual Developmental
`Disorder) (41)
`
`mmunication Disorders (41)
`
`.32 $30.23.)
`
`Language Disorder (42)
`
`39 (E3300)
`‘35 teaser;
`
`Speech Sound Disorder (44)
`Childhood—Onset Fluency Disorder (Stuttering) (45)
`Note: Later-onset cases are diagnosed as 307.0 (F985) adult—onset fluency
`disorder.
`
`39 $30.82)
`
`Social (Pragmatic) Communication Disorder (47)
`
`5338095?)
`
`Page 15 of114
`
`SLAYBACK EXHIBIT 1024
`
`
`
`Page 15 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`
`
`DSM—5 Classification
`
`Autism Spectrum Disorder (50)
`
`299.00 {sac-is;
`
`Autism Spectrum Disorder (50)
`Specify if: Associated with a known medical or genetic condition or envi—
`ronmental factor; Associated with another neurodevelopmental, men~
`tal, or behavioral disorder
`
`Speczfy current severity for Criterion A and Criterion B: Requiring very
`substantial support, Requiring substantial support, Requiring support
`Specify if: With or without accompanying intellectual impairment, With
`or without accompanying language impairment, With catatonia (use
`additional code 293.89 [F06.1l)
`
`Specify it: With motor tics only, With vocal tics only
`
`AttentionDeficit/Hyperactivity Disorder (59)
`
`‘2
`
`Attention ~Deficit / Hyperactivity Disorder (59)
`Specify whether:
`Combined presentation
`
`Predominantly inattentive presentation
`
`314.01 @9035}
`
`Predominantly hyperactive / impulsive presentation
`Specify if: In partial remission
`Specify current severity: Mild, Moderate, Severe
`
`314.01 {$610.5)
`
`Other Specified Attention—Deficit/ Hyperactivity Disorder (65)
`
`314.01 WE‘QQEE
`
`Unspecified Attention—Deficit/ Hyperactivity Disorder (66)
`
`Specific Learning Disorder (66)
`
`_-_ i. W}
`
`315.00 (9%“: .0}
`
`315.2 {PM 53?}
`
`315.1 {53? .2}
`
`Specific Learning Disorder (66)
`Specify if:
`
`With impairment in reading (specify if with word reading
`accuracy, reading rate or fluency, reading comprehension)
`With impairment in written expression (specify if with spelling
`accuracy, grammar and punctuation accuracy, clarity or
`organization of written expression)
`With impairment in mathematics (specify it with number sense,
`memorization of arithmetic facts, accurate or fluent
`
`calculation, accurate math reasoning)
`Specify current severity: Mild, Moderate, Severe
`
`Motor Disorders (74)
`
`315.4 (332%
`
`DevelopmentalCoordination Disorder (74)
`
`307.3 {tritisflii
`
`Tic Disorders
`
`Stereotypic Movement Disorder (77)
`Specify if: With self—injurious behavior, Without self—injurious behavior
`Speczfy if: Associated. with a known medical or genetic condition, neuro—
`developmental disorder, or environmental factor
`Specify current severity: Mild, Moderate, Severe
`
`307.23 {$35.2}
`
`Tourette's Disorder (81)
`
`307.22 iggiiifli
`
`Persistent (Chronic) Motor or Vocal Tic Disorder (81)
`
`Page 16 of 114
`
`SLAYBACK EXHIBIT 1024
`
`Page 16 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`B: Requiring very
`iiequiring support
`im '
`:
`t,
`‘
`pal] men Wlth
`(ith catatonia (use
`
`ation
`
`Disorder (65)
`irder 66
`(
`
`)
`
`g
`
`d reading
`Dlnprehension)
`fw'th-
`11‘
`1
`s e in
`p
`lC , cl arit
`y
`
`y or
`
` M—5 Classification DSM—5 Classification
`
`Em
`C32
` Provisional Tic Disorder (81)
`W.
`307.21
`
`i
`yin %J!
`.89;
`Other Specified Tic Disorder (85)
`
`
`307.20 é
`i
`condition or envi-
`
`
`an
`307.20 é a
`velopmen tal, men—
`
`
`
` Other Neurodevelopmental Disorders (86)
`
`
`3153 $383)
`Other Specified Neurodevelopmental Disorder (86)
`
`
`.
`.
`..
`.
`315.9 t¥$§§§ Unspec1f1ed Neurodevelopmental Disorder (86)
`
`
`
`
`
`
`
`
`
`
`
`Schizophrenia Spectrum
`and Other P5V°h°tl° DiS,°Fq9'§l3?l .
` The following specifiers apply to Schizophrenia Spectrum and Other Psychotic Disorders
`
`where indicated:
`
`aSpecI'fy if: The following course specifiers are only to be used after a 'l—year duration of the dis-
`order: First episode, currently in acute episod e; First episode, currently in partial remission;
`
`First episode, currently in full remission; Multiple episodes, currently in acute episode; Mu1~
`tiple episodes, currently in partial remission; Multiple episodes, currently in full remission;
`
` Continuous; Unspecified
`
`bSpecify it: With catatonia (use additional code 293.89 [F06.l])
`.
`CSpecrfy current severity of delusions, hallucinations, disorganized speech, abnormal psycho-
`
`
`motor behavior, negative symptoms, impaired cognition, depression, and mania symptoms
`
`
`
`
`
`
`
`
`number sense,
`
`)r fluent
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`293.81 {titsfifit
`
`293.82 éirfifiétl
`
`
`Delusional Disordera’ C (90)
`Speci y whether: Erotomanic type, Grandiose type, Jealous type, Persecu—
`tory type, Somatic type, Mixed type, Unspecified type
`Specify if; With bizarre content
`,
`Brief Psychotic Disorderb' L (94)
`Specify if: With marked stressor(s), Without marked stressor(s), With
`peripartum onset
`Schizophreniform Disorderb' C (96)
`Specify if: With good prognostic features, Without good prognostic fea-
`tures
`
`.9}:
`
`Unspecified Tic Disorder (85)
`
`301.22 $21;
`
`Schizotypal (Personality) Disorder (90)
`
`297.1
`
`{”3322}
`
`298.8
`
`tees}
`
`295.40 teaser)
`
`295.90 {was}
`
`Schizophreniaa' b! C (99)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ious behavior
`inditi on, neuro~
`
`
`
`295.70 {37235.63}
`295.70 (£753.31)
`
`*.__ {W 7 }
`
`l)
`
` W
`
`Schizoaffective Disorder?“ bl C (105)
`Specify whether:
`Bipolar type
`Depressive type
`
`Substance / Medication-Induced Psychotic DisorderC (110)
`Note: See the criteria set and corresponding recording procedures for
`substance—specific codes and lCD—9—CM and lCD-10~CM coding.
`Specify if: With onset during intoxication, With onset during withdrawal
`
`Psychotic Disorder Due to Another Medical ConditionC (115)
`Speczfy whether:
`With delusions
`With hallucinations
`
`
`
` Page 17 of 114 SLAYBACK EXHIBIT 1024
`
`
`
`Page 17 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`293.89 (1366.?)
`
`293.89 ((506.1)
`293.89 (F936?)
`
`298.8
`
`{$528}
`
`298.9
`
`(F29)
`
`DSM-5 Classification
`
`Catatonia Associated With Another Mental Disorder (Catatonia
`Specifier) (119)
`Catatonic Disorder Due to Another Medical Condition (120)
`Unspecified Catatonia (121)
`Note: Code first 781.99 (R29.818) other symptoms involving nervous and
`musculoskeletal systems.
`Other Specified Schizophrenia Spectrum and Other Psychotic
`DisOrder (122)
`Unspecified Schizophrenia Spectrum and Other Psychotic
`Disorder (122)
`
`
`
`where indicated:
`
`a8pcc1fy: With anxious distress (spectfy current severity: mild, moderate, moderate-severe, severe);
`With mixed features; With rapid cycling; With melancholic features; With atypical features;
`With mood-congruent psychotic features; With mood-incongruent psychotic features; With
`catatonia (use additional code 293.89 [F06.1]); With peripartum onset; With seasonal pattern
`_-~ t.......»__,l
`Bipolar I Disordera (123)
`E _ (MM “Wt
`Current or most recent episode manic
`296.41 {531.11}
`Mild
`296.42 (53:31.?2)
`Moderate
`296.43 {5731. i3)
`Severe
`296.44 ($315 .2)
`With psychotic features
`296.45 ($31573)
`In partial remission
`296.46 ($3?.?4§
`In full remission
`296.40 {533? .9?)
`Unspecified
`296.40 (5333? .52}
`Current Or most recent episode hypomanic
`296.45 (£53???)
`In partial remission
`296.46 {ngfg‘é}
`In full remission
`296.40 (F3? $3
`Unspecified
`.
`Current or most recent episode depressed
`Mild
`Moderate
`Severe
`With psychotic features
`In partial remission
`In full remission
`Unspecified
`Current or most recent episode unspecified
`Bipolar II Disordera (132)
`Specify current or most recent
`Specify course if full criteria fo‘
`partial remission, In full remission
`wpacify severity if full criteria for a m '
`met: Mild, Moderate, Severe
`
`296.52 {F3132}
`296.53 (£933? .6}
`296.54 (53"?5)
`296.55 {$3‘i15)
`296.56 {553.31%}
`296.50 ($31.9)
`296.7
`(933.5%)
`296.89 {5316?}
`
`Page 18 of114
`
`SLAYBACK EXHIBIT 1024
`
`Page 18 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`“Mm..“gm-‘wwme“MNQWMWMMcw.an have.» 9.; WWW...“- -..4.....- -_A MW...» m .WWW-._...m.w..
`
`.c.
`
`.
`
`..._.M,.M_...._.,,.___.,...,,,,,
`
`. .
`
`1—5 Classification
`
`DSM—S Classification
`
`xvii
`
`301.13 (934.9)
`
`Cyclothymic Disorder (139)
`Specify if: With anxious distress
`
`.M._ t_______.11}
`
`293.83 {Mb}
`
`($06.33)
`
`(969.39;
`(999.39;
`
`Substance /Medication-Induced Bipolar and Related Disorder (1412)
`Note: See the criteria set and corresponding recording procedures for
`substance-specific codes and lCD—9—CM and ICD-IO—CM coding.
`Specify if: With onset during intoxication, With onset during withdrawal
`
`Bipolar and Related Disorder Due to Another Medical Condition
`(145)
`Specify if:
`With manic features
`
`With manic— or hypomanic~like episode
`With mixed features
`
`296.89 (1:31 .89)
`
`Other Specified Bipolar and Related Disorder (148)
`
`296.80 (F313)
`
`Unspecified Bipolar and Related Disorder (149)
`
`
`
`der (Catatonia
`
`lition (120)
`
`Ving nervous and
`
`er Psychotic
`
`sychotic
`
`
`
`lted:
`
`te—severe, severe);
`atypical features;
`'ic features; With
`asonal pattern
`
`essed
`
`Jrrently met: In
`
`:1e are currently
`
`“1...
`
`;_
`
`._ ,_,..
`
`_ _,., ..
`
`.MM _.
`
`-Psweseive Piss’rders (155)
`The following specifiers apply to Depressive Disorders where indicated:
`“Specify: With anxious distress (specify current severity: mild, moderate, moderate—severe,
`severe); With mixed features; With melancholic features; With atypical features; With mood-
`congruent psychotic features; With mood—incongruent psychotic features; With catatonia
`(use additional code 293.89 [FO6.1]); With peripartum onset; With seasonal pattern
`
`296.99 ($34.81)
`
`Disruptive Mood Dysregulation Disorder (156)
`
`“We... Lee.)
`
`_-W i..........1»)
`296.21 (99213)
`296.22 (932.1}
`296.23 (992.2;
`296.24 (932.3}
`296.25 {992.4}
`296.26 (939.5}
`296.20 (939.9}
`_._ (was.-.)
`296.31 ($33.91
`296.32 {5333.11
`296.33 {$33.2}
`296.34 (F333)
`296.35 ($33.41)
`296.36 (F3342)
`296.30 (F333)
`
`300.4
`
`($34.1)
`
`Major Depressive Disordera (160)
`Single episode
`Mild
`Moderate
`Severe
`
`With psychotic features
`In partial remission
`In full remission
`
`Unspecified
`Recurrent episode
`Mild
`Moderate
`Severe
`
`With psychotic features
`In partial remission
`In full remission
`
`Unspecified
`
`Persistent Depressive Disorder (Dysthymia)a (168)
`Specify if: In partial remission, In full remission
`Specify if: Early onset, Late onset
`Specify if: With pure dysthymic syndrome; With persistent major depres-
`sive episode; With intermittent major depressive episodes, With current
`
`mam
`
` Page 19 of 114 SLAYBACK EXHIBIT 1024
`
`
`
`Page 19 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`DSM—S Classification
`
`episode; With intermittent major depressive episodes, without current
`episode
`Specify current severity: Mild, Moderate, Severe
`
`625.4 33233
`
`Premenstrual Dysphoric Disorder (171)
`
`M.” S 7, 3 Substance/Medication—lnduced Depressive Disorder (175)
`Note: See the criteria set and corresponding recording procedures for
`substance—specific codes and ICD—9—CM and ICD-lO-CM coding.
`Specify if: With onset during intoxication, With onset during withdrawal
`
`Depressive Disorder Due to Another Medical Condition (180)
`Specify if:
`
`With depressive features
`
`With major depressive—like episode
`With mixed features
`
`Other Specified Depressive Disorder (183)
`
`Unspecified Depressive Disorder (184)
`
`.. Anxiety Disorders (1893”
`309.21 53333.33
`Separation Anxiety Disorder (190)
`
`313.23 53:33.33
`
`Selective Mutism (195)
`
`300.29 51..” ,
`
`3
`
`(3343. 23:3 3}
`33/33. 22383
`
`Specific Phobia (197)
`Specify if:
`Animal
`Natural environment
`
`Blood—injection—injury
`Fear of blood
`
`Fear of injections and transfusions
`Fear of other medical care
`
`With onset after medication use
`
`é,
`awn}
`317533.233}
`
`5343.233}
`335133323
`
`€ 3 {
`
`{3:33.233}
`{343.2433
`{343.2333
`
`Fear of injury
`Situational
`Other
`
`300.23 ‘353331; 33
`
`Social Anxiety Disorder (Social Phobia) (202)
`Specify if: Performance only
`
`300.01 (33133.33
`
`Panic Disorder (208)
`
`_ __ {
`
`KW3
`
`Panic Attack Specifier (214)
`
`300.22 {3:43.333 Agoraphobia (217)
`
`300.02 {3333.33
`
`Generalized Anxiety Disorder (222)
`
`Substance/Medication-ind uced Anxiety Disord er (226)
`Note: See the criteria set and corresponding recording procedures for
`substance-specific codes and ICD-9-CM and lCD~10—CM coding.
`Specify if: With onset during intoxication, With onset during withdrawal,
`
`Page 20 of 114
`
`SLAYBACK EXHIBIT 1024
`
`Page 20 of 114
`
`SLAYBACK EXHIBIT 1024
`
`

`

`
`
`Vl-5 Classification
`
`6' WlthOUt current
`
`
`DSM-5 Classification
`
`293.84 {503.4}
`Anxiety Disorder Due to Another Medical Condition (230)
`
`300.09 {$541.3}
`
`Other Specified Anxiety Disorder (233)
`
`‘der (175)
`1g proced ures for
`CM coding.
`iring withdrawal
`1diti0n (180)
`
`300.7
`
`(€345.22)
`
`300.3
`
`(F423)
`
`Body Dysmorphic Disordera (242)
`Specify if: With muscle dysmorphia
`
`Hoarding Disordera (247)
`Specify if: With excessive acquisition
`
`312.39 {F333}
`
`Trichotillomania (Hair-Pulling Disorder) (251)
`
`698.4
`
`{Psi/2.4)
`
`Excoriation (Skin-Picking) Disorder (254)
`
`
`
`_.._-_ iNNNNNNN.W)
`
`294.8
`
`$533.8)
`
`Obsessive-Compulsive and Related Disorder Due to Another
`Medical Condition (260)
`Speczfy if: With obsessive-compulsive disorder—like symptoms, With
`appearance preoccupations, With hoarding symptoms, With hair—
`pulling symptoms, With skin—picking symptoms
`
`300.3
`
`(542.3)
`
`Other Specified Obsessive-Compulsive and Related Disorder
`(263)
`
`300.3
`
`Unspecified Obsessive~Compulsive and Related Disorder (264)
`(542.9)
`
`
`
`313.89 €534.12)
`
`309.81 (234333}?
`
`Disinhibited Social Engagement Disorder (268)
`Specify if: Persistent
`Specify current severity: Severe
`
`
`
`
`
`Unspecified Anxiety Disorder (233)
`300.00 {Mira}
`
`
`
`
`N”
`”WWWWWWWWWW
`m
`
`
`
`m Obsesswe-Compulswe and Related Dlsorders (235)
`_.
`
`
`The follOWing Specifier applies to Obsess1ve—Compuls1ve and RelatedDlsorders where 1nd1cated
`
`
`aSpecify if: With good or fan insight With p001 insight, With absent 11151ght/delus1onal beliefs
`
`
`300.3
`{542.2}
`Obsessive-Compulsive Disordera (237)
`
`
`Specify if: Tic—related
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Trauma- and Stressor-Related Dlsorders (265)
` 313.89 (£3341) Reactive Attachment Disorder (265)
`
`
`Specify if: Persistent
`
`
`Specify current severity: Severe
`
`
`
`
`
`
`26)
`.l’osttraumatic Stress Disorder (includes Posttraumatic Stress
`
`
`Jrocedures for
`Disorder for Children 6 Years and Younger) (271)
`
`
`[ COd-ing.
`Specify whether: With dissociative symptoms
`
`
`1g Wj-thdl‘aWEll,
`Specify if: With delayed expression
`Acute Stress Disorder (280) 308.3 {543.0}
`
`Substance/Medication-Induced Obsessive—Compulsive and
`Related Disorder (257)
`Note: See the criteria set and corresponding recording procedures for
`substance—specific codes and ICD—9—CM and ICD—l 0—CM coding.
`Specify if: With onset durin